United States · Who invested in BioClin Therapeutics?
BioClin Therapeutics's investors include Sofinnova Investments, Life Sciences Partners, Tekla Capital and Ysios Capital/ HealthCap.
20132014201520162017
$20MSeries A$6.0MSeries A$30MSeries BUnited States · Series B startup
Who invested in BioClin Therapeutics
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$56Mraised across 3 rounds since 2012, from 3 sources
$20MSeries A$6.0MSeries A$30MSeries B
- Latest round
- Series B, $30MMar 2017
- Step-upi
- 5×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $20M Dec 2012
- Biggest round
- $30M Series B · Mar 2017
- Usual gap between rounds
- 3 years the median of 2
The rounds
- Mar 2017Series B$30M4 new
Sofinnova Investments- Life Sciences Partners
- Tekla Capital
- Ysios Capital/ HealthCap
Reported by FinSMEsSEC filing: $20M sold, first sale Mar 2017
- Apr 2014Series A$6.0M
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Apr 2014
- Dec 2012Series A$20M
No investor was named in the report.
From a historical funding record
Founders and team
From the SEC filings it signed: 3 on the team.
- Stephen W. LauPresident, Chief Executive Officer, and Treasureri
- Graeme L. CurrieChief Operating Officeri
- Steve L. AbellaChief Medical Officeri
On the board, as filediChristian L. RichardDavid L. KabakoffFouad L. AzzamJoel L. Jean-MairetJoseph L. TurnerMarten L. Steen
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2012Series A2014Series B2017Sofinnova InvestmentsLife Sciences PartnersTekla CapitalYsios Capital/ HealthCap
Sofinnova InvestmentsLife Sciences PartnersTekla CapitalYsios Capital/ HealthCapEveryone who backed them
Life Sciences PartnersGrowth equity1round
Tekla Capitalno record of our own yet1round
Ysios Capital/ HealthCapno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about BioClin Therapeutics
How much has BioClin Therapeutics raised?
BioClin Therapeutics has raised $56M across 3 rounds since 2012.
When did BioClin Therapeutics last raise?
BioClin Therapeutics's most recent round was a Series B of $30M in Mar 2017.
What was BioClin Therapeutics's biggest round?
Its most recent round, $30M in Mar 2017, is also its largest on record.
Who backed BioClin Therapeutics first?
BioClin Therapeutics's first round on record, in Mar 2017, was backed by Sofinnova Investments, Life Sciences Partners and Tekla Capital and 1 others.
What stage is BioClin Therapeutics at?
BioClin Therapeutics's latest named round is a Series B, in Mar 2017.
Where is BioClin Therapeutics based?
BioClin Therapeutics is based in the United States.
Companies like BioClin Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.